Home

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund (BIVF) invests in groundbreaking therapeutics-focused biotechnology companies to drive innovation in biomedical research. BIVF is searching for significant enhancements in patient care through pioneering science and its clinical translation by building long-term relationships with scientists and entrepreneurs. BIVF’s focus is to target unprecedented therapeutic concepts addressing high medical needs in immuno-oncology, regenerative medicine, infectious diseases and digital health. These may include novel platform technologies to address so far undruggable targets, new generation vaccines and/or new biological entities, such as oncolytic virotherapy.
Investor Type:
Corporate VC
HQ Location:
Germany
Investment Areas:
Biotechnology, Finance, Venture Capital,
Typical Investment:
€100k-€1.5M
Funding Stage:
Pre-Seed / Seed, Series A/B
Contact Email:
[email protected]